(redirected from Namenda)
Also found in: Medical.
Related to Namenda: Memantine, Exelon


A drug, C20H24N5O4, used in its hydrochloride form to treat symptoms of Alzheimer's disease by inhibiting NMDA receptors.

[me(thyl) + (ada)mant(ane), molecule with a diamond-like structure (from Greek adamās, adamant-, diamond; see adamant) + -ine.]


n memantina
References in periodicals archive ?
Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/mL, the therapeutic similar to the reference listed drug Namenda Oral Solution, 2 mg/mL of Forest Pharmaceuticals.
The attorney-general of New York, Eric Schneiderman, won a preliminary injunction to stop the drug company Actavis and its subsidiary Forest Laboratories from withdrawing an older version of Namenda, a drug to treat moderate-to-severe Alzheimer's disease with a patent that expires in July, and replacing it with a newer version covered by a patent that would extend until 2029.
NYSE:FRX), has made plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.
Actavis will add the Alzheimer's disease treatment Namenda and newer drugs like the antidepressant Viibryd to its product portfolio with the latest in a string of multibillion-dollar acquisitions that have swelled the drugmaker's size in recent years.
Several drugs such as Namenda and Aricept that work for people with Alzheimer's have been tested without success in people with MS.
Memantine, sold under the brand name Namenda, works by binding to certain brain cell receptors in order to block the activity of the neurotransmitter glutamate, which has been shown to kill nerve cells at high levels.
Current therapies for the disease, including Namenda from Forest Laboratories Inc.
KgaA, and Merz Pharmaceuticals GmbH have filed a second lawsuit in the United States District Court for the District of Delaware against additional companies for infringement of United States Patent 5,061,703 (the '703 patent), which relates to Forest's Namenda product.
Namenda is designed to help restore adequate glutamate levels in the brain.
Namenda is now being tested in people with earlier stages of the disease, he noted.
government approval for Alzheimer's, including the latest, called memantine or Namenda, does more than slow or temporarily stop mental deterioration.